-
公开(公告)号:US20050070689A1
公开(公告)日:2005-03-31
申请号:US10485489
申请日:2002-07-24
申请人: Vishva Dixit , Iqbal Grewal , John Ridgway , Minhong Yan
发明人: Vishva Dixit , Iqbal Grewal , John Ridgway , Minhong Yan
IPC分类号: G01N33/50 , A61K38/00 , A61K39/395 , A61P1/02 , A61P1/04 , A61P3/10 , A61P5/14 , A61P7/06 , A61P9/00 , A61P9/12 , A61P11/00 , A61P11/06 , A61P13/00 , A61P13/12 , A61P17/00 , A61P19/02 , A61P19/08 , A61P21/04 , A61P27/02 , A61P29/00 , A61P31/04 , A61P31/10 , A61P31/20 , A61P35/00 , A61P37/02 , A61P43/00 , C07K14/715 , C07K16/28 , C07K19/00 , C12N20060101 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12P21/02 , C12P21/08 , C12Q1/02 , G01N33/15 , C07K14/705 , C07H21/04 , C12N1/18 , C12N5/06 , C12N15/74
CPC分类号: C07K16/2878 , A61K38/00 , C07K14/7151
摘要: Novel, receptors, referred to herein as “TACIs” and “BR3”, agonists and antagonists thereof, and method of using TACIs and BR3, as well as agonists and antagonists thereof, to modulate, for example, activity of tumor necrosis factor (TNF) and TNFR-related molecules, including members of the TNF and TNFR families referred to as TALL-1, APRIL, TACI, and BCMA, are provided. Methods for in vitro, in situ, and/or in vivo diagnosis and/or treatment of mammalian cells or pathological conditions associated with such TNF and TNFR-related molecules are further provided.
摘要翻译: 新颖的受体,本文称为“TACI”和“BR3”,其激动剂和拮抗剂,以及使用TACI和BR3以及其激动剂和拮抗剂的方法调节肿瘤坏死因子(TNF)的活性 )和TNFR相关分子,包括称为TALL-1,APRIL,TACI和BCMA的TNF和TNFR家族的成员。 还提供了用于体外,原位和/或体内诊断和/或治疗与这种TNF和TNFR相关分子相关的哺乳动物细胞或病理状况的方法。
-
公开(公告)号:US20110045474A1
公开(公告)日:2011-02-24
申请号:US12826537
申请日:2010-06-29
申请人: David Dornan , Dorothy French , Vishva Dixit
发明人: David Dornan , Dorothy French , Vishva Dixit
CPC分类号: G01N33/57496 , G01N33/574 , G01N2333/9015 , G01N2500/02 , G01N2800/52
摘要: The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.
摘要翻译: 本发明提供用于检测各种癌症中COP1过表达的诊断,预后和治疗用途。 所述方法和用途还可以包括检测p53表达。 本发明还提供用于筛选干扰COP1和p53结合的测试化合物的试剂和试剂盒。
-
3.
公开(公告)号:US20070004009A1
公开(公告)日:2007-01-04
申请号:US11454670
申请日:2006-06-15
申请人: Vishva Dixit , Robert Hamilton , Jana van de Goor
发明人: Vishva Dixit , Robert Hamilton , Jana van de Goor
CPC分类号: C12P21/02 , C07K14/005 , C07K14/8139 , C12N1/38 , C12N7/00 , C12N9/6475 , C12N15/67 , C12N2500/36 , C12N2500/92 , C12N2501/48 , C12N2510/02 , C12N2710/14022
摘要: The invention provided improved methods of making and producing recombinant proteins in in vitro cultures of host cells using apoptosis inhibitors. The use of one or more apoptosis inhibitors in the methods can reduce apoptosis in the cell cultures and markedly improve yield of the desired recombinant proteins.
摘要翻译: 本发明提供了使用凋亡抑制剂在体外培养宿主细胞中制备和产生重组蛋白质的改进方法。 在该方法中使用一种或多种凋亡抑制剂可以减少细胞培养物中的凋亡并显着提高所需重组蛋白的产量。
-
公开(公告)号:US20050089984A1
公开(公告)日:2005-04-28
申请号:US10961148
申请日:2004-10-12
申请人: Vishva Dixit , Wei-Wu He , Kristine Kikly , Steven Ruben
发明人: Vishva Dixit , Wei-Wu He , Kristine Kikly , Steven Ruben
IPC分类号: C12N15/09 , A61K38/00 , A61K38/55 , A61K39/395 , A61K45/00 , A61K48/00 , A61P9/10 , A61P25/00 , A61P25/28 , A61P31/04 , A61P43/00 , C07K14/47 , C07K16/40 , C12N5/00 , C12N5/10 , C12N9/64 , C12N9/99 , C12N15/12 , C12Q1/68 , C12R1/91 , C07H21/04
CPC分类号: C12N9/6475 , A61K38/00 , A61K48/00
摘要: Human ICE LAP-6 polypeptides and DNA (RNA) encoding such ICE LAP-6 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such ICE LAP-6 for the treatment of a susceptibility to viral infection, tumorogenesis and to diseases and defects in the control embryogenesis and tissue homeostasis, and the nucleic acid sequences described above may be employed in an assay for ascertaining such susceptibility. Antagonists against such ICE LAP-6 and their use as a therapeutic to treat Alzheimer's disease, Parkinson's disease, rheumatoid arthritis, septic shock, sepsis, stroke, chronic inflammation, acute inflammation, CNS inflammation, osteoporosis, ischemia reperfusion injury, cell death associated with cardiovascular disease, polycystic kidney disease, apoptosis of endothelial cells in cardiovascular disease, degenerative liver disease, MS, ALS, cererbellar degeneration, ischemic injury, myocardial infarction, AIDS, myelodysplastic syndromes, aplastic anemia, male pattern baldness, and head injury damage are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the interleukin-1 beta converting enzyme apoptosis proteases and for detecting altered levels of the polypeptide in a host.
摘要翻译: 公开了人ICE LAP-6多肽和编码这种ICE LAP-6的DNA(RNA)和通过重组技术产生这种多肽的方法。 还公开了利用这种ICE LAP-6用于治疗对病毒感染,肿瘤发生的易感性以及控制胚胎发生和组织稳态中的疾病和缺陷的方法,并且上述核酸序列可用于确定 这种敏感性。 对抗这种ICE LAP-6的拮抗剂及其作为治疗性阿尔茨海默病,帕金森病,类风湿性关节炎,败血性休克,败血症,中风,慢性炎症,急性炎症,CNS炎症,骨质疏松症,缺血再灌注损伤,与 心血管疾病,多囊肾病,心血管疾病中的内皮细胞凋亡,退行性肝病,MS,ALS,小脑变性,缺血性损伤,心肌梗塞,艾滋病,骨髓增生异常综合征,再生障碍性贫血,男性型秃发和头部损伤也是 披露 还公开了用于检测与核酸序列中的突变和多肽的改变的浓度相关的疾病的诊断测定。 还公开了用于检测编码白细胞介素-1β转换酶凋亡蛋白酶的多核苷酸中的突变并用于检测宿主中多肽的改变水平的诊断测定法。
-
公开(公告)号:US08992919B2
公开(公告)日:2015-03-31
申请号:US13086941
申请日:2011-04-14
IPC分类号: A61K39/395 , C07K16/18
CPC分类号: C07K16/18 , C07K14/4702 , C07K2317/24 , C07K2317/30 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/92 , C12N15/1037 , G01N33/68 , G01N2333/4703 , G01N2440/36
摘要: The invention provides anti-polyubiquitin antibodies and methods of using the same.
摘要翻译: 本发明提供抗多聚遍在蛋白抗体及其使用方法。
-
公开(公告)号:US20130058955A1
公开(公告)日:2013-03-07
申请号:US13567919
申请日:2012-08-06
IPC分类号: A61K39/395 , C12N15/63 , C12N5/10 , C12N1/21 , C12N1/15 , A61P25/00 , C12P21/02 , G01N33/566 , C07K16/18 , C07K16/46 , A61P35/00 , A61P21/00 , C12N15/13 , C12N1/19
CPC分类号: C07K16/18 , C07K16/40 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/55 , C07K2317/565 , C07K2317/92 , G01N33/68
摘要: The invention provides anti-polyubiquitin antibodies and methods of using the same.
-
公开(公告)号:US20080057066A1
公开(公告)日:2008-03-06
申请号:US11674074
申请日:2007-02-12
申请人: Vishva Dixit , Nobuhiko Kayagaki , Yan Wu
发明人: Vishva Dixit , Nobuhiko Kayagaki , Yan Wu
IPC分类号: A61K31/70 , A61K39/395 , A61P43/00 , C07K16/18 , C12N15/00 , C12N15/11 , C12N5/06 , C12P21/04 , G01N33/53
CPC分类号: G01N33/6893 , A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/03 , C07K14/70575 , C07K16/2878 , C07K2317/24 , C07K2317/54 , C07K2317/565 , C07K2317/75 , C07K2317/92 , C12N15/8509 , G01N33/564 , G01N33/56972 , G01N33/57492 , G01N2800/104 , G01N2800/24
摘要: Anti-RELT monoclonal antibodies, and methods for using the antibodies, are provided. Methods of using RELT polypeptides and nucleic acids in modulating immune cell development and in modulating cytokine production are also provided.
摘要翻译: 提供抗RELT单克隆抗体,以及使用抗体的方法。 还提供了使用RELT多肽和核酸调节免疫细胞发育和调节细胞因子产生的方法。
-
公开(公告)号:US20080009458A1
公开(公告)日:2008-01-10
申请号:US11786399
申请日:2007-04-10
申请人: David Dornan , Dorothy French , Vishva Dixit
发明人: David Dornan , Dorothy French , Vishva Dixit
CPC分类号: G01N33/57496 , G01N33/574 , G01N2333/9015 , G01N2500/02 , G01N2800/52
摘要: The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.
摘要翻译: 本发明提供用于检测多种癌症中COP1过表达的诊断,预后和治疗用途。 所述方法和用途还可包括检测p53表达。 本发明还提供用于筛选干扰COP1和p53结合的测试化合物的试剂和试剂盒。
-
公开(公告)号:US07785815B2
公开(公告)日:2010-08-31
申请号:US11786399
申请日:2007-04-10
申请人: David Dornan , Dorothy French , Vishva Dixit
发明人: David Dornan , Dorothy French , Vishva Dixit
CPC分类号: G01N33/57496 , G01N33/574 , G01N2333/9015 , G01N2500/02 , G01N2800/52
摘要: The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.
摘要翻译: 本发明提供用于检测多种癌症中COP1过表达的诊断,预后和治疗用途。 所述方法和用途还可包括检测p53表达。 本发明还提供用于筛选干扰COP1和p53结合的测试化合物的试剂和试剂盒。
-
公开(公告)号:US20050244857A1
公开(公告)日:2005-11-03
申请号:US11076187
申请日:2005-03-10
申请人: Jian Ni , Craig Rosen , James Pan , Reiner Gentz , Vishva Dixit
发明人: Jian Ni , Craig Rosen , James Pan , Reiner Gentz , Vishva Dixit
IPC分类号: C12N15/09 , C07H21/04 , C07K14/705 , C07K16/28 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/12 , C12P21/02 , C12P21/06 , C12Q1/68
CPC分类号: C07K14/70578
摘要: The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides. The invention also relates to the treatment of diseases associated with reduced or increased levels of apoptosis using antibodies specific for DR4, which may be agonists and/or antagonists of DR4 activity.
-
-
-
-
-
-
-
-
-